Jerry Krishnan to Pulmonary Disease, Chronic Obstructive
This is a "connection" page, showing publications Jerry Krishnan has written about Pulmonary Disease, Chronic Obstructive.
Connection Strength
20.021
-
A Hybrid Effectiveness/Implementation Clinical Trial of Adherence to Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2023 11; 20(11):1561-1570.
Score: 0.746
-
Yet Another Crack in the Facade of the Centers for Medicare and Medicaid Services Hospital Readmissions Reduction Program for Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2023 01 01; 207(1):2-4.
Score: 0.704
-
Telehealth in chronic obstructive pulmonary disease: before, during, and after the coronavirus disease 2019 pandemic. Curr Opin Pulm Med. 2022 03 01; 28(2):93-98.
Score: 0.665
-
Time to Revisit the Hospital Readmissions Reduction Program for Patients Hospitalized for Chronic Obstructive Pulmonary Disease Exacerbations. Am J Respir Crit Care Med. 2021 02 15; 203(4):403-404.
Score: 0.619
-
Home Oxygen Therapy for Patients With COPD: Time for a Reboot. Respir Care. 2019 Dec; 64(12):1574-1585.
Score: 0.569
-
Prevalence and Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Routine Primary Care Practices. Ann Am Thorac Soc. 2019 09; 16(9):1143-1150.
Score: 0.559
-
Patient registries for home oxygen research and evaluation. Int J Chron Obstruct Pulmon Dis. 2019; 14:1299-1304.
Score: 0.551
-
How Long Should We Be Vigilant after a Hospitalization for a Chronic Obstructive Pulmonary Disease Exacerbation? Am J Respir Crit Care Med. 2018 04 15; 197(8):975-977.
Score: 0.508
-
Effectiveness of Interventions to Teach Metered-Dose and Diskus Inhaler Techniques. A Randomized Trial. Ann Am Thorac Soc. 2016 06; 13(6):816-24.
Score: 0.446
-
COPD Bundle to Prevent Hospital Readmissions and ED Visits. Chest. 2015 Sep; 148(3):e91.
Score: 0.424
-
Reducing the risk of rehospitalization in patients with chronic obstructive pulmonary disease exacerbations. Fewer known unknowns. Ann Am Thorac Soc. 2014 Jun; 11(5):797-8.
Score: 0.388
-
What is the right dose of systemic corticosteroids for intensive care unit patients with chronic obstructive pulmonary disease exacerbations? A question in search of a definitive answer. Am J Respir Crit Care Med. 2014 May 01; 189(9):1014-6.
Score: 0.386
-
Confirmatory spirometry for adults hospitalized with a diagnosis of asthma or chronic obstructive pulmonary disease exacerbation. BMC Pulm Med. 2012 Dec 07; 12:73.
Score: 0.351
-
Stakeholder priorities for comparative effectiveness research in chronic obstructive pulmonary disease: a workshop report. Am J Respir Crit Care Med. 2013 Feb 01; 187(3):320-6.
Score: 0.349
-
Teaching the use of respiratory inhalers to hospitalized patients with asthma or COPD: a randomized trial. J Gen Intern Med. 2012 Oct; 27(10):1317-25.
Score: 0.337
-
Prioritizing comparative-effectiveness research topics via stakeholder involvement: an application in COPD. Clin Pharmacol Ther. 2011 Dec; 90(6):888-92.
Score: 0.325
-
High frequency chest wall oscillation for asthma and chronic obstructive pulmonary disease exacerbations: a randomized sham-controlled clinical trial. Respir Res. 2011 Sep 10; 12:120.
Score: 0.322
-
The validity of International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes for identifying patients hospitalized for COPD exacerbations. Chest. 2012 Jan; 141(1):87-93.
Score: 0.318
-
Misuse of respiratory inhalers in hospitalized patients with asthma or COPD. J Gen Intern Med. 2011 Jun; 26(6):635-42.
Score: 0.308
-
Acting on comparative effectiveness research in COPD. JAMA. 2010 Jun 16; 303(23):2409-10.
Score: 0.295
-
Hospitalizations for acute exacerbations of chronic obstructive pulmonary disease: how you count matters. COPD. 2010 Jun; 7(3):164-71.
Score: 0.294
-
Sex differences in survival of oxygen-dependent patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 Sep 01; 174(5):524-9.
Score: 0.224
-
Real-world treatment trajectories of adults with newly diagnosed asthma or COPD. BMJ Open Respir Res. 2024 02 27; 11(1).
Score: 0.191
-
Lifestyle Intervention and Excess Weight in Chronic Obstructive Pulmonary Disease (COPD): INSIGHT COPD Randomized Clinical Trial. Ann Am Thorac Soc. 2023 12; 20(12):1743-1751.
Score: 0.188
-
African American race is associated with worse sleep quality in heavy smokers. J Clin Sleep Med. 2023 08 01; 19(8):1523-1532.
Score: 0.183
-
Genetic regulators of sputum mucin concentration and their associations with COPD phenotypes. PLoS Genet. 2023 06; 19(6):e1010445.
Score: 0.182
-
A blood and bronchoalveolar lavage protein signature of rapid FEV1 decline in smoking-associated COPD. Sci Rep. 2023 05 22; 13(1):8228.
Score: 0.181
-
Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICS. Clin Immunol. 2023 05; 250:109324.
Score: 0.179
-
Roflumilast May Increase Risk of Exacerbations When Used to Treat Poorly Controlled Asthma in People with Obesity. Ann Am Thorac Soc. 2023 02; 20(2):206-214.
Score: 0.177
-
Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD. Chest. 2023 03; 163(3):502-514.
Score: 0.175
-
Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS. Respir Res. 2022 Nov 14; 23(1):310.
Score: 0.175
-
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function. N Engl J Med. 2022 09 29; 387(13):1173-1184.
Score: 0.172
-
Reversible Airflow Obstruction Predicts Future Chronic Obstructive Pulmonary Disease Development in the SPIROMICS Cohort: An Observational Cohort Study. Am J Respir Crit Care Med. 2022 09 01; 206(5):554-562.
Score: 0.172
-
Risk of COPD exacerbation is increased by poor sleep quality and modified by social adversity. Sleep. 2022 08 11; 45(8).
Score: 0.171
-
Association Among Chronic Obstructive Pulmonary Disease Severity, Exacerbation Risk, and Anxiety and Depression Symptoms in the SPIROMICS Cohort. J Acad Consult Liaison Psychiatry. 2023 Jan-Feb; 64(1):45-57.
Score: 0.171
-
Reconsidering the Utility of Race-Specific Lung Function Prediction Equations. Am J Respir Crit Care Med. 2022 04 01; 205(7):819-829.
Score: 0.167
-
Ambient ozone effects on respiratory outcomes among smokers modified by neighborhood poverty: An analysis of SPIROMICS AIR. Sci Total Environ. 2022 Jul 10; 829:154694.
Score: 0.167
-
Comparative Impact of Depressive Symptoms and FEV1% on Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2022 02; 19(2):171-178.
Score: 0.165
-
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward. Am J Respir Crit Care Med. 2022 02 01; 205(3):275-287.
Score: 0.165
-
Clinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A Post Hoc Analysis of the COPDGene and SPIROMICS Cohorts. Ann Am Thorac Soc. 2022 01; 19(1):143-146.
Score: 0.164
-
Defining Resilience to Smoking-related Lung Disease: A Modified Delphi Approach from SPIROMICS. Ann Am Thorac Soc. 2021 11; 18(11):1822-1831.
Score: 0.162
-
Racial Segregation and Respiratory Outcomes among Urban Black Residents with and at Risk of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021 09 01; 204(5):536-545.
Score: 0.161
-
Disparities in access to food and chronic obstructive pulmonary disease (COPD)-related outcomes: a cross-sectional analysis. BMC Pulm Med. 2021 Apr 27; 21(1):139.
Score: 0.157
-
Contribution of Individual and Neighborhood Factors to Racial Disparities in Respiratory Outcomes. Am J Respir Crit Care Med. 2021 04 15; 203(8):987-997.
Score: 0.156
-
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers. Am J Respir Crit Care Med. 2021 04 15; 203(8):957-968.
Score: 0.156
-
The influence of social support on COPD outcomes mediated by depression. PLoS One. 2021; 16(3):e0245478.
Score: 0.156
-
Reassessment of Home Oxygen Prescription after Hospitalization for Chronic Obstructive Pulmonary Disease. A Potential Target for Deimplementation. Ann Am Thorac Soc. 2021 03; 18(3):426-432.
Score: 0.155
-
Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort. NPJ Biofilms Microbiomes. 2021 02 05; 7(1):14.
Score: 0.154
-
Ratio of FEV1/Slow Vital Capacity of < 0.7 Is Associated With Clinical, Functional, and Radiologic Features of Obstructive Lung Disease in Smokers With Preserved Lung Function. Chest. 2021 07; 160(1):94-103.
Score: 0.154
-
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 11 15; 202(10):e121-e141.
Score: 0.152
-
Home Oxygen Evaluation by Respiratory Therapists in Patients Hospitalized for COPD Exacerbations: The RIsOTTO Study. Respir Care. 2021 02; 66(2):183-190.
Score: 0.149
-
Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort. Int J Chron Obstruct Pulmon Dis. 2020; 15:1887-1898.
Score: 0.149
-
Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene. Chest. 2020 12; 158(6):2333-2345.
Score: 0.147
-
The Association Between Neighborhood Socioeconomic Disadvantage and Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2020; 15:981-993.
Score: 0.146
-
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 05 01; 201(9):e56-e69.
Score: 0.146
-
Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort. JCI Insight. 2020 02 13; 5(3).
Score: 0.144
-
Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD: An Analysis of the SPIROMICS Cohort. Chest. 2020 04; 157(4):856-865.
Score: 0.143
-
Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis. Int J Chron Obstruct Pulmon Dis. 2019; 14:2927-2938.
Score: 0.143
-
Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS. Eur Respir J. 2019 10; 54(4).
Score: 0.141
-
A Genetic Risk Score Associated with Chronic Obstructive Pulmonary Disease Susceptibility and Lung Structure on Computed Tomography. Am J Respir Crit Care Med. 2019 09 15; 200(6):721-731.
Score: 0.140
-
Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study. Sci Rep. 2019 08 06; 9(1):11367.
Score: 0.139
-
Poor Metered-Dose Inhaler Technique Is Associated with Overuse of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2019 06; 16(6):765-768.
Score: 0.137
-
Characteristics at the time of oxygen initiation associated with its adherence: Findings from the COPD Long-term Oxygen Treatment Trial. Respir Med. 2019 03; 149:52-58.
Score: 0.135
-
Alignment of Inhaled Chronic Obstructive Pulmonary Disease Therapies with Published Strategies. Analysis of the Global Initiative for Chronic Obstructive Lung Disease Recommendations in SPIROMICS. Ann Am Thorac Soc. 2019 02; 16(2):200-208.
Score: 0.134
-
Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report. Ann Am Thorac Soc. 2019 02; 16(2):161-170.
Score: 0.134
-
Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS. Chest. 2019 05; 155(5):908-917.
Score: 0.134
-
Aspirin Use and Respiratory Morbidity in COPD: A Propensity Score-Matched Analysis in Subpopulations and Intermediate Outcome Measures in COPD Study. Chest. 2019 03; 155(3):519-527.
Score: 0.133
-
Incorporating telemedicine into the integrated care of the COPD patient a summary of an interdisciplinary workshop held in Stresa, Italy, 7-8 September 2017. Respir Med. 2018 10; 143:91-102.
Score: 0.131
-
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort. Respir Med. 2018 07; 140:87-93.
Score: 0.128
-
Home Oxygen in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2018 05 15; 197(10):1254-1264.
Score: 0.128
-
Sleep disruption as a predictor of quality of life among patients in the subpopulations and intermediate outcome measures in COPD study (SPIROMICS). Sleep. 2018 05 01; 41(5).
Score: 0.127
-
Pulmonary rehabilitation for patients with COPD during and after an exacerbation-related hospitalisation: back to the future? Eur Respir J. 2018 01; 51(1).
Score: 0.125
-
Hospital Procalcitonin Testing and Antibiotic Treatment of Patients Admitted for Chronic Obstructive Pulmonary Disease Exacerbation. Ann Am Thorac Soc. 2017 Dec; 14(12):1779-1785.
Score: 0.124
-
Sleep Disturbance in Smokers with Preserved Pulmonary Function and with Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2017 Dec; 14(12):1836-1843.
Score: 0.124
-
Prevention of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017 09; 50(3).
Score: 0.122
-
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort. Lancet Respir Med. 2017 08; 5(8):619-626.
Score: 0.120
-
Respiratory Symptoms Items from the COPD Assessment Test Identify Ever-Smokers with Preserved Lung Function at Higher Risk for Poor Respiratory Outcomes. An Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort. Ann Am Thorac Soc. 2017 May; 14(5):636-642.
Score: 0.119
-
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2017 03; 49(3).
Score: 0.118
-
Positive Airway Pressure Therapies and Hospitalization in Chronic Obstructive Pulmonary Disease. Am J Med. 2017 07; 130(7):809-818.
Score: 0.116
-
Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. 2016 09; 13(9):1490-6.
Score: 0.114
-
Patient Involvement in the Design of a Patient-Centered Clinical Trial to Promote Adherence to Supplemental Oxygen Therapy in COPD. Patient. 2016 06; 9(3):271-9.
Score: 0.112
-
Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. Lancet Respir Med. 2016 06; 4(6):473-526.
Score: 0.111
-
COPD Hospitalization Risk Increased with Distinct Patterns of Multiple Systems Comorbidities Unveiled by Network Modeling. AMIA Annu Symp Proc. 2014; 2014:855-64.
Score: 0.100
-
Multicenter study comparing case definitions used to identify patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014 Nov 01; 190(9):989-95.
Score: 0.100
-
Disability and recovery of independent function in obstructive lung disease: the cardiovascular health study. Respiration. 2014; 88(4):329-38.
Score: 0.099
-
Measuring health-related quality of life in chronic obstructive pulmonary disease: properties of the EQ-5D-5L and PROMIS-43 short form. BMC Med Res Methodol. 2014 Jun 16; 14:78.
Score: 0.097
-
Interventions to reduce rehospitalizations after chronic obstructive pulmonary disease exacerbations. A systematic review. Ann Am Thorac Soc. 2014 Mar; 11(3):417-24.
Score: 0.095
-
Chronic obstructive pulmonary disease readmissions at minority-serving institutions. Ann Am Thorac Soc. 2013 Dec; 10(6):680-4.
Score: 0.094
-
Development, validation, and results of a risk-standardized measure of hospital 30-day mortality for patients with exacerbation of chronic obstructive pulmonary disease. J Hosp Med. 2013 Aug; 8(8):428-35.
Score: 0.092
-
Effects of respiratory and non-respiratory factors on disability among older adults with airway obstruction: the Cardiovascular Health Study. COPD. 2013 Oct; 10(5):588-96.
Score: 0.091
-
The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med. 2012 Jul 09; 12:26.
Score: 0.085
-
Comparative effectiveness research in chronic obstructive pulmonary disease. J Comp Eff Res. 2012 Jan; 1(1):71-82.
Score: 0.082
-
Outcomes of noninvasive ventilation for acute exacerbations of chronic obstructive pulmonary disease in the United States, 1998-2008. Am J Respir Crit Care Med. 2012 Jan 15; 185(2):152-9.
Score: 0.081
-
Educational and research advances stemming from the Academic Emergency Medicine consensus conference in knowledge translation. Acad Emerg Med. 2010 Aug; 17(8):865-9.
Score: 0.074
-
Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease. Arch Intern Med. 2009 Aug 10; 169(15):1403-10.
Score: 0.070
-
CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J. 2010 Jan; 35(1):132-7.
Score: 0.069
-
Longitudinal Follow-Up of Participants With Tobacco Exposure and Preserved Spirometry. JAMA. 2023 08 01; 330(5):442-453.
Score: 0.046
-
In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med. 2003 May 26; 163(10):1180-6.
Score: 0.045
-
Genetic and non-genetic factors affecting the expression of COVID-19-relevant genes in the large airway epithelium. Genome Med. 2021 04 21; 13(1):66.
Score: 0.039
-
Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study. Respir Med. 2017 02; 123:1-7.
Score: 0.029
-
Prevalence of hiatal hernia by blinded multidetector CT in patients with idiopathic pulmonary fibrosis. Eur Respir J. 2012 Feb; 39(2):344-51.
Score: 0.020